San Salvatore Hospital Researcher Yields New Data on Antiretrovirals (Analysing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicentre cohort of virologically suppressed PLWHIV)

Source :: Obesity, Fitness & Wellness Week. November 12, 2022, 6513
Publication Year :: 2022
Abstract: 2022 NOV 12 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on antiretrovirals. According to news reporting originating from [...]

Subjects :: Lamivudine -- Dosage and administration -- Patient outcomes
Rilpivirine -- Dosage and administration -- Patient outcomes
Drug therapy, Combination -- Usage -- Patient outcomes
HIV infection -- Drug therapy -- Patient outcomes
Health

Tools